Filing Details

Accession Number:
0001062993-24-003878
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-21 16:10:11
Reporting Period:
2024-02-16
Accepted Time:
2024-02-21 16:10:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1850119 Century Therapeutics Inc. IPSC Biological Products, (No Disgnostic Substances) (2836) 842040295
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1867310 Adrienne Farid C/O Century Therapeutics, Inc.
25 N 38Th Street, 11Th Floor
Philadelphia PA 19104
Chief Operations Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-16 485 $1.03 114,634 No 4 M Direct
Common Stock Disposition 2024-02-16 485 $4.86 114,149 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2024-02-16 485 $0.00 485 $1.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
222,170 2029-07-17 No 4 M Direct
Footnotes
  1. The transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2022.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.85 to $4.865, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The option is fully vested and exercisable.